Liver Cancer
FEATURES
avatar
1757 clinical trials
avatar
82 cell line models
avatar
6 approved drugs
IMAGE
Liver Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

6 drugs have received FDA approval for Liver Cancer:

  • Cabozantinib-S-Malate
  • Lenvatinib Mesylate
  • Nivolumab
  • Pembrolizumab
  • Regorafenib
More

284 drugs have a clinical trial registered for Liver Cancer.

7245 compounds have been tested in Liver Cancer (4425 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 1757 clinical trials for Liver Cancer, 886 of which have one or more drug interventions, 871 with no drug intervention.
Cell line models

There are 82 Cell Line Models for Liver Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Liver Cancer:
  • Hepatoblastoma
  • Liver Neoplasms
  • Liver Neoplasms, Experimental
  • Carcinoma, Hepatocellular
The following terms have been mapped from cancer.gov to Liver Cancer:
  • Hepatocellular carcinoma (a type of liver cancer). It is used in patients who have already been treated with sorafenib
  • Hepatocellular carcinoma (a type of liver cancer) in patients who have been treated with sorafenib.????
  • Hepatocellular carcinoma (a type of liver cancer). It is used as first-line treatment in patients whose disease cannot be removed by surgery
  • Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery
  • Hepatocellular carcinoma (a type of liver cancer). It is used in patients who have already been treated with sorafenib. This use is approved for the Cabometyx brand of cabozantinib-s-malate